Shehnaaz Suliman - 16 Jun 2026 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Reporting relationship: Director
Issuer ticker: TXG
Reported as of: 16 Jun 2026
Net transaction value: -$186,756
SEC form: 4
Accepted by SEC: 18 Jun 2026, 16:08:03 UTC
Prior SEC filing: 08 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Randy Wu, as Attorney-in-Fact for Shehnaaz Suliman

Key filing fact

Shehnaaz Suliman filed Form 4 for 10x Genomics, Inc. (TXG) on 18 Jun 2026.

Key facts

This page summarizes Shehnaaz Suliman's Form 4 filing for 10x Genomics, Inc. (TXG).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 18 Jun 2026, 16:08.

Change

Previous filing in this sequence was filed on 08 Jun 2026.
Current net transaction value: -$186,756.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001713070 Primary reporting owner

SULIMAN SHEHNAAZ

Relationship: Director
Address: C/O 10X GENOMICS, INC., 6230 STONERIDGE MALL ROAD, PLEASANTON
Signature: /s/ Randy Wu, as Attorney-in-Fact for Shehnaaz Suliman
Signature date: 18 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TXG transaction

Class A Common Stock

Sale

Transaction value: $174,644
Shares: -5,359
Change %: -14%
Price: $32.59
Shares after: 32,086
Date: 16 Jun 2026
Ownership: Direct
Footnotes: F1, F2

TXG transaction

Class A Common Stock

Sale

Transaction value: $12,112
Shares: -364
Change %: -1.1%
Price: $33.27
Shares after: 31,722
Date: 16 Jun 2026
Ownership: Direct
Footnotes: F1, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 3 footnotes

Footnote F1

The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 13, 2026.

Footnote F2

This transaction was executed in multiple trades at prices ranging from $32.03 to $33.02, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Footnote F3

This transaction was executed in multiple trades at prices ranging from $33.03 to $33.49, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.